Anna M. Di Giacomo
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2026
A Real-World Experience of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma.
Journal: Cancers
Published: December 12, 2025
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
Journal: Clinical drug investigation
Published: December 09, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
Journal: The New England journal of medicine
Published: October 22, 2025
Approaches to overcome the current treatment plateau in immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 01, 2025
Neurological adverse events of ICI therapy: A ten-year comprehensive management from a multidisciplinary team.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 26, 2025
Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma.
Journal: Future oncology (London, England)
Published: June 12, 2025
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 01, 2025
Last Updated: 09/26/2026